OPKO Health Statistics
Total Valuation
OPKO Health has a market cap or net worth of GBP 793.14 million. The enterprise value is 840.59 million.
Market Cap | 793.14M |
Enterprise Value | 840.59M |
Important Dates
The next estimated earnings date is Wednesday, July 30, 2025.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 793.05M |
Shares Outstanding | n/a |
Shares Change (YoY) | -7.48% |
Shares Change (QoQ) | -29.44% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 376.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.49 |
PB Ratio | 0.78 |
P/TBV Ratio | 14.34 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -27.85 |
EV / Sales | 1.65 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -5.27 |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.38.
Current Ratio | 2.49 |
Quick Ratio | 1.80 |
Debt / Equity | 0.38 |
Debt / EBITDA | n/a |
Debt / FCF | -2.39 |
Interest Coverage | -4.87 |
Financial Efficiency
Return on equity (ROE) is -3.04% and return on invested capital (ROIC) is -9.68%.
Return on Equity (ROE) | -3.04% |
Return on Assets (ROA) | -8.20% |
Return on Invested Capital (ROIC) | -9.68% |
Return on Capital Employed (ROCE) | -14.69% |
Revenue Per Employee | 178,043 |
Profits Per Employee | -10,072 |
Employee Count | 2,997 |
Asset Turnover | 0.34 |
Inventory Turnover | 9.48 |
Taxes
In the past 12 months, OPKO Health has paid 29.74 million in taxes.
Income Tax | 29.74M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.38% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +5.38% |
50-Day Moving Average | 1.33 |
200-Day Moving Average | 1.51 |
Relative Strength Index (RSI) | 51.29 |
Average Volume (20 Days) | 14,372 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 10.67 |
Income Statement
In the last 12 months, OPKO Health had revenue of GBP 533.59 million and -30.19 million in losses. Loss per share was -0.04.
Revenue | 533.59M |
Gross Profit | 81.22M |
Operating Income | -208.40M |
Pretax Income | -446,592 |
Net Income | -30.19M |
EBITDA | -134.22M |
EBIT | -208.40M |
Loss Per Share | -0.04 |
Balance Sheet
The company has 331.91 million in cash and 381.49 million in debt, giving a net cash position of -49.58 million.
Cash & Cash Equivalents | 331.91M |
Total Debt | 381.49M |
Net Cash | -49.58M |
Net Cash Per Share | n/a |
Equity (Book Value) | 1.02B |
Book Value Per Share | 1.51 |
Working Capital | 341.91M |
Cash Flow
In the last 12 months, operating cash flow was -141.24 million and capital expenditures -18.39 million, giving a free cash flow of -159.63 million.
Operating Cash Flow | -141.24M |
Capital Expenditures | -18.39M |
Free Cash Flow | -159.63M |
FCF Per Share | n/a |
Margins
Gross margin is 15.22%, with operating and profit margins of -39.06% and -5.66%.
Gross Margin | 15.22% |
Operating Margin | -39.06% |
Pretax Margin | -0.08% |
Profit Margin | -5.66% |
EBITDA Margin | -25.15% |
EBIT Margin | -39.06% |
FCF Margin | n/a |
Dividends & Yields
OPKO Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 7.48% |
Shareholder Yield | n/a |
Earnings Yield | -3.81% |
FCF Yield | -20.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
OPKO Health has an Altman Z-Score of -0.5 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.5 |
Piotroski F-Score | 2 |